Incidence and mortality of herpes simplex encephalitis in Denmark : A nationwide registry-based cohort study
Copyright © 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved..
OBJECTIVES: We aimed to investigate the incidence and mortality of herpes simplex encephalitis (HSE) in a nationwide cohort.
METHODS: From the Danish National Patient Registry, we identified all adults hospitalised with a first-time diagnosis of HSE in Denmark during 2004-2014. The HSE diagnoses were verified using medical records and microbiological data. Patients were followed for mortality through the Danish Civil Registry System. We estimated age-standardised incidence rates of HSE and 30-day, 60-day, and 1-year cumulative mortality. Furthermore, we assessed whether calendar year, age, gender, level of comorbidity, virus type, and department type was associated with HSE mortality.
RESULTS: We identified a total of 230 cases of HSE. Median age was 60.7 years (interquartile range: 49.3-71.6). The overall incidence rate was 4.64 cases per million population per year (95% confidence interval: 4.06-5.28). The cumulative mortality within 30 days, 60 days, and 1 year of the HSE admission was 8.3%, 11.3%, and 18.6%, respectively. Advanced age and presence of comorbidity were associated with increased 60-day and 1-year mortality.
CONCLUSIONS: This nationwide study of verified HSE found a higher incidence than reported in previous nationwide studies. Presence of comorbidity was identified as a novel adverse prognostic factor. Mortality rates following HSE remain high.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2017 |
---|---|
Erschienen: |
2017 |
Enthalten in: |
Zur Gesamtaufnahme - volume:74 |
---|---|
Enthalten in: |
The Journal of infection - 74(2017), 1 vom: 01. Jan., Seite 42-49 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jørgensen, Laura Krogh [VerfasserIn] |
---|
Links: |
---|
Themen: |
Comorbidity |
---|
Anmerkungen: |
Date Completed 12.10.2017 Date Revised 27.06.2018 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jinf.2016.09.004 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM265116953 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM265116953 | ||
003 | DE-627 | ||
005 | 20231224211600.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231224s2017 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jinf.2016.09.004 |2 doi | |
028 | 5 | 2 | |a pubmed24n0883.xml |
035 | |a (DE-627)NLM265116953 | ||
035 | |a (NLM)27717782 | ||
035 | |a (PII)S0163-4453(16)30243-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jørgensen, Laura Krogh |e verfasserin |4 aut | |
245 | 1 | 0 | |a Incidence and mortality of herpes simplex encephalitis in Denmark |b A nationwide registry-based cohort study |
264 | 1 | |c 2017 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 12.10.2017 | ||
500 | |a Date Revised 27.06.2018 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2016 The British Infection Association. Published by Elsevier Ltd. All rights reserved. | ||
520 | |a OBJECTIVES: We aimed to investigate the incidence and mortality of herpes simplex encephalitis (HSE) in a nationwide cohort | ||
520 | |a METHODS: From the Danish National Patient Registry, we identified all adults hospitalised with a first-time diagnosis of HSE in Denmark during 2004-2014. The HSE diagnoses were verified using medical records and microbiological data. Patients were followed for mortality through the Danish Civil Registry System. We estimated age-standardised incidence rates of HSE and 30-day, 60-day, and 1-year cumulative mortality. Furthermore, we assessed whether calendar year, age, gender, level of comorbidity, virus type, and department type was associated with HSE mortality | ||
520 | |a RESULTS: We identified a total of 230 cases of HSE. Median age was 60.7 years (interquartile range: 49.3-71.6). The overall incidence rate was 4.64 cases per million population per year (95% confidence interval: 4.06-5.28). The cumulative mortality within 30 days, 60 days, and 1 year of the HSE admission was 8.3%, 11.3%, and 18.6%, respectively. Advanced age and presence of comorbidity were associated with increased 60-day and 1-year mortality | ||
520 | |a CONCLUSIONS: This nationwide study of verified HSE found a higher incidence than reported in previous nationwide studies. Presence of comorbidity was identified as a novel adverse prognostic factor. Mortality rates following HSE remain high | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Comorbidity | |
650 | 4 | |a Epidemiology | |
650 | 4 | |a Herpes simplex encephalitis | |
650 | 4 | |a Herpes simplex virus | |
650 | 4 | |a Incidence | |
650 | 4 | |a Mortality | |
650 | 4 | |a Prognosis | |
650 | 4 | |a Viral encephalitis | |
700 | 1 | |a Dalgaard, Lars Skov |e verfasserin |4 aut | |
700 | 1 | |a Østergaard, Lars Jørgen |e verfasserin |4 aut | |
700 | 1 | |a Nørgaard, Mette |e verfasserin |4 aut | |
700 | 1 | |a Mogensen, Trine Hyrup |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of infection |d 1982 |g 74(2017), 1 vom: 01. Jan., Seite 42-49 |w (DE-627)NLM012791822 |x 1532-2742 |7 nnns |
773 | 1 | 8 | |g volume:74 |g year:2017 |g number:1 |g day:01 |g month:01 |g pages:42-49 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jinf.2016.09.004 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 74 |j 2017 |e 1 |b 01 |c 01 |h 42-49 |